We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGIO
451
DELISTED
Edgio, Inc. Common Stock
EGIO
$113K 0.02%
2,500
– –
LUMN icon
452
Lumen
LUMN
$6.09B
$107K 0.02%
20,550
– –
AMRN
453
Amarin Corp
AMRN
$301M
$106K 0.02%
4,400
– –
EVC icon
454
Entravision Communication
EVC
$1.05B
$106K 0.02%
22,000
– –
HA
455
DELISTED
Hawaiian Holdings, Inc.
HA
$103K 0.02%
10,000
– –
GT icon
456
Goodyear
GT
$1.94B
$102K 0.02%
10,000
– –
RMNI icon
457
Rimini Street
RMNI
$462M
$91.4K 0.01%
24,000
– –
OABI icon
458
OmniAb
OABI
$325M
$88.2K 0.01%
+24,500
New +$129K
BHR
459
Braemar Hotels & Resorts
BHR
$146M
$87.5K 0.01%
21,300
– –
BRSP
460
BrightSpire Capital
BRSP
$639M
$87.2K 0.01%
14,000
– –
USX
461
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$85.1K 0.01%
47,000
– –
VERI icon
462
Veritone
VERI
$116M
$84.8K 0.01%
16,000
– –
ACTG icon
463
Acacia Research
ACTG
$451M
$84.2K 0.01%
20,000
– –
SCWX
464
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$83.1K 0.01%
13,000
– –
WVE icon
465
Wave Life Sciences
WVE
$1.19B
$81.9K 0.01%
11,700
– –
WW
466
DELISTED
WW International
WW
$73.3K 0.01%
19,000
– –
SFE
467
DELISTED
Safeguard Scientifics, Inc.
SFE
$70.8K 0.01%
22,833
– –
TUP
468
DELISTED
Tupperware Brands Corporation
TUP
$66.2K 0.01%
16,000
– –
ESPR
469
DELISTED
Esperion Therapeutics
ESPR
$63.1K 0.01%
10,125
– –
BBBY
470
DELISTED
Bed Bath & Beyond Inc
BBBY
$60.2K 0.01%
24,000
– –
TRHC
471
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$49.5K 0.01%
10,000
– –
CHS
472
DELISTED
Chicos FAS, Inc.
CHS
$49.2K 0.01%
10,000
– –
MAGN
473
Magnera Corp
MAGN
$446M
$44.5K 0.01%
1,231
– –
RDI icon
474
Reading International Class A
RDI
$35.2M
$37.4K 0.01%
13,500
– –
SNCR
475
DELISTED
Synchronoss Technologies
SNCR
$33.4K 0.01%
6,000
– –
16 17 18
19
20

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.